Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Grayson

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Open Forum Infectious Diseases|July 30, 2024
Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeMary Czech, Jennifer Cuellar-Rodriguez, Bhavisha A Patel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2015
Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisPeter C Grayson, Carmelo Carmona-Rivera, Lijing Xu, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
Arthritis Care & Research|August 25, 2019
Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell ArteritisK Bates Gribbons, Cristina Ponte, Simon Carette, et al.
Rheumatology (Oxford, England)|October 4, 2019
Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North AmericaRuchika Goel, K Bates Gribbons, Simon Carette, et al.
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Open Forum Infectious Diseases|July 30, 2024
Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeMary Czech, Jennifer Cuellar-Rodriguez, Bhavisha A Patel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2015
Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated VasculitisPeter C Grayson, Carmelo Carmona-Rivera, Lijing Xu, et al.
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
Arthritis Care & Research|August 25, 2019
Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell ArteritisK Bates Gribbons, Cristina Ponte, Simon Carette, et al.
Rheumatology (Oxford, England)|October 4, 2019
Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North AmericaRuchika Goel, K Bates Gribbons, Simon Carette, et al.
Annals of the Rheumatic Diseases|February 16, 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, et al.
Annals of the Rheumatic Diseases|February 24, 2023
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumaticaChristian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Annals of the Rheumatic Diseases|July 30, 2025
A glossary of signs and symptoms of giant cell arteritisMedha L Soowamber, Milena Bond, Zahi Touma, et al.
Pageof 17